TITLE
Imatinib effects on chronic myelogenous leukemia CD34+ cells

SUMMARY
Comparison of purified bone marrow CD34+ cells from imatinib-treated chronic myelogenous leukemia (CML) patients and healthy donors.

ORGANISM
Homo sapiens

